Latest
News
Check out the latest news and announcements from Hippo T&C
Press Release September 1, 2023
[IFA 2023] K-Small and Medium Enterprises and Startups Forge Global Expansion Gateway Beyond Europe
#IFA2023#Exhibition#AttnKare
Read More Notice September 1, 2023
AttnKare-D by Hippo T&C on Display at Seongnam GXG 2023
#GXG2023#AttnKare#Exhibition
Read More Press Release July 28, 2023
Psychiatry secures research funding from South Korea
#UNMC#Funding#Clinical Trial
Read More Notice June 21, 2023
AttnKare-D to Conduct Clinical Trials with the University of Nebraska Medical Center in the U.S.
#Clinical Trial#UNMC#AttnKare
Read More Press Release April 6, 2023
Tai-Myoung Chung, CEO of Hippo T&C, stated, "We are establishing a U.S. corporation and intensifying our efforts to penetrate the North American market! "
#Tai-Myoung Chung#Interview
Read More Notice April 3, 2023
Hippo T&C Unveils Three Self-Developed Digital Therapeutic Devices
#Hippo T&C Showcase
Read More Notice January 23, 2023
Hippo T&C Showcases Three Products at APSARD
#APSARD2023#AttnKare#BlueKare
Read More Press Release January 18, 2023
[Issue] Treating Illness with Digital Therapeutics Instead of Medications... Consumer Commercialization Approaches
#DTx#AttnKare#BlueKare
Read More Press Release January 17, 2023
Hippo T&C to Expand Distribution of Digital Therapeutics for ADHD, Depression, and Diabetic Foot Care This Year
#CES2023#AttnKare#BlueKare
Read More Press Release January 9, 2023
[CES 2023] Korean Startups Soar and Business Leaders Gather: Focus on Metaverse, Mobility, and Sustainability
#CES2023
Read More Press Release December 17, 2022
2022 Korea ICT Awards: 9 Companies Honored in 4 Categories
#2022 Korea ICT Awards#Special Awards
Read More Press Release September 19, 2022
Security Expert Turns Digital Therapeutics Entrepreneur: "Contributing to Society with Software Knowledge"
#Clinical Trial#AttnKare#Startup
Read More